Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma, Synovial 1Sarcoma 1Neurofibrosarcoma 1Leiomyosarcoma 1Histiocytoma, Malignant Fibrous 1Dermatofibrosarcoma 1

Interventions

Doxorubicin 4Radiotherapy 3belinostat 2Trabectedin 2Gemcitabine 2selinexor 1sargramostim 1peposertib 1pembrolizumab 1olaratumab 1liposomal doxorubicin 1itacitinib 1futibatinib 1cixutumumab 1baricitinib 1avelumab 1Specimen Handling 1Radiation 1PTC596 1Nivolumab 1Magnetic Resonance Spectroscopy 1Ifosfamide 1INCB039110 1Fluorouracil 1Erlotinib Hydrochloride 1Dacarbazine 1Chemotherapy, Adjuvant 1Celecoxib 1Biopsy 1BO-112 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Leiomyosarcoma × BO-112 × Clear all
NCT04420975 2026-03-10

Nivolumab and BO-112 Before Surgery for the Treatment of Resectable Soft Tissue Sarcoma

Jonsson Comprehensive Cancer Center

Phase 1 Active not recruiting
14 enrolled
Sarcoma

Leiomyosarcoma, Sarcoma, Sarcoma, Synovial, Dermatofibrosarcoma, Neurofibrosarcoma, Histiocytoma, Malignant Fibrous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡